Unit outline_

PHAR5723: Immunology and Cancer

Semester 1, 2026 [Normal day] - Camperdown/Darlington, Sydney

This unit of study integrates pharmaceutical sciences and pharmacy-practice content relating to the treatment of oncological and immunological conditions. The unit will cover the pharmaceutical sciences that underpin drug therapies used in managing these conditions; the physiology, epidemiology, pathophysiology and clinical features of the conditions; and practice-related aspects in professional pharmacy services including disease state management, familiarisation with computerised drug information databases and vaccination training. Knowledge gained is applied in case-based scenarios, workshops, and role plays, where students have the opportunity to assimilate the learnt information and apply them to optimise the pharmacological and nonpharmacological management of patients with these conditions. Interprofessional communication and the application of knowledge through clinical interventions and/or medication management review will also be explored. 

Unit details and rules

Academic unit Pharmacy
Credit points 6
Prerequisites
? 
PHAR5911 and PHAR5712 and PHAR5713 and PHAR5714 and PHAR5715 and PHAR5716 and PHAR5717 and PHAR5718
Corequisites
? 
PHAR5721 and PHAR5722
Prohibitions
? 
None
Assumed knowledge
? 

None

Available to study abroad and exchange students

No

Teaching staff

Coordinator Jennifer Ong, jennifer.ong@sydney.edu.au
The census date for this unit availability is 31 March 2026
Type Description Weight Due Length Use of AI
Written exam hurdle task Written Exam
Multiple choice questions and short answer questions
50% Formal exam period 2 hours AI prohibited
Outcomes assessed: LO1 LO2 LO3 LO4 LO5 LO6 LO7
Oral exam hurdle task OSCE
Oral examination
30% Formal exam period 2 hours AI prohibited
Outcomes assessed: LO1 LO2 LO3 LO4 LO5 LO6 LO7
In-class quiz Tutorial Assessments
Quizzes, participation in case tutorials
20% Ongoing 12 x 3 hours (Each tutorial) AI allowed
Outcomes assessed: LO1 LO2 LO3 LO4 LO5 LO6 LO7 LO8
hurdle task = hurdle task ?

Assessment summary

  • Tutorial assessments: The tutorials are designed to help students integrate and apply the knowledge and skills acquired in lectures and other related activities, in the management of patients’ health needs and problems, and other clinical issues they are likely to encounter as a practising pharmacist. The tutorials will emphasise the application of ‘processes’ in practising as a pharmacist, especially communication processes incorporating information gathering, information processing, and information delivery. The students are expected to do pre-work prior to the tutorial. Tutorials will make up 20% of the Unit of Study mark, with 10 marks allocated for two HMR report/letters, 5 marks for tutorial quizzes (3 quizzes over the semester) and 5 marks for tutorial participation i.e., must complete pre-work, attend tutorial, participate in group discussions and behave in a professional manner. 
     
  • No use of AI tools (Final Exam, OSCE)
    The use of automated writing tools and generative artificial intelligence is prohibited in this assessment. You are not allowed to use AI or any other software to create information or answers, to alter your own original writing, or to generate or modify text from other sources. This includes translation software, editing/paraphrasing software and other generative artificial intelligence tools.
    Unapproved use is considered a breach of the Academic Integrity Policy and may result in penalties, which can include a fail for the assessment.
     
  • AI tools permitted (All other assessments)
    The use of AI tools is optional. You are permitted to use automated writing tools and generative artificial intelligence (AI) to facilitate your learning and completion of this assignment.  Please adhere to the following guidelines:
    -    Do not enter confidential, personal, copyrighted or otherwise sensitive information into any AI tool.
    -    Do not rely on the accuracy of outputs. You remain responsible for your work. This means you must independently verify and edit AI-generated content to ensure the integrity, accuracy, and suitability of the output.
    -    If you use these tools, you must be aware of their limitations, biases, and propensity for fabrication.
    Your final submitted work must be your own, original work. You must acknowledge any use of AI tools that have been used in the assessment, and any material that forms part of your submission, must be appropriately referenced. For guidance on how to reference and acknowledge the use of AI, please refer to the AI in Education Canvas site.
    You are advised to keep copies of the prompts you provided and AI outputs as evidence of your research and writing process. This allows you to produce an accurate acknowledgement of AI use when you submit your work. This can be requested by the unit coordinator if there is any uncertainty about the originality of your work.
  • In this assessment you are allowed to use automated writing tools and artificial intelligence (AI) for the following purposes:
    Editing assistance - You may use automated writing or AI tools such as Cogniti to provide feedback on your work and suggest readability improvements to your text in terms of grammar and expression. You cannot use generative AI tools to generate content.
    Generating ideas for assessment - You may use AI tools such as Cogniti to brainstorm initial ideas and approaches for completing your assignment. However, you must develop or edit those ideas to a substantial degree to ensure your submission is your own, original work. 
    Creating media for assessment - You may use AI tools such as Cogniti to generate media that you use as part of your submission.
    Suggesting a structure or outline - You may use AI tools such as Cogniti to help you draft an outline for your work.
    Searching and summarising literature- You may use AI tools such as Cogniti to find and summarise research articles. The generated summary should not be included in the submission. You need to incorporate the scholarship yourself into your submission. 
    Your final submitted work must be your own, original work. You must acknowledge any use of AI tools that have been used in the assessment, and any material that forms part of your submission, must be appropriately referenced. For guidance on how to reference and acknowledge the use of AI, please refer to the AI in Education Canvas site.
    Please adhere to the following guidelines: 
    Do not enter confidential, personal, copyrighted or otherwise sensitive information into any AI tool. If you use these tools, you must be aware of their limitations, biases, and propensity for fabrication. 
    Do not rely on the accuracy of outputs. You remain responsible for your work. This means you must independently verify and edit AI-generated content to ensure the integrity, accuracy, and suitability of the output.
    Failure to declare the use of AI tools is considered a breach of the Academic Integrity Policy and may result in penalties, which can include a fail for the assessment.
    You are advised to keep copies of the prompts you provided and AI outputs as evidence of your research and writing process. This allows you to produce an accurate acknowledgement of AI use when you submit your work. This can be requested by the unit coordinator if there is any uncertainty about the originality of your work.

  • OSCE: The Objective Structured Clinical Examination (OSCE) is a role-play assessment of communication skills and clinical knowledge competence as a pharmacist. It is linked to 3 therapeutic units PHAR5721, PHAR5722 and PHAR5723. Students will be given corresponding cases to prepare prior to the assessment. On OSCE day, each student will sit three stations; each station corresponds to one unit of study (PHAR5721, PHAR5722, PHAR5723). Within each station, each student sits two cases - a patient case (communicating with an examiner role-playing a pseudo-patient) and a doctor case (communicating with an examiner role-playing a pseudo-doctor). Each student must pass the average of both cases per station to pass the corresponding unit of study (ie: obtain 50% on the average of both cases per station).
     
  • Written examination: The written exam will comprise a mixture of both multiple-choice and short-answer questions. These questions will include all content covered in lectures and tutorials and tutorial preparation materials. You must pass (50%) in the written exam to pass the unit of study

Detailed information for each assessment can be found on Canvas.

Supplementary Yr assessments: Students may be offered re-assessment of compulsory-to-pass assessments in the Main and Replacement exam periods as described in the relevant local provisions. 

Repeating students: Exemption from components (tutorials) for students repeating PHAR5723 will not be granted. 

Assessment criteria

The University awards common result grades, set out in the Coursework Policy (Schedule 1).

As a general guide, a high distinction indicates work of an exceptional standard, a distinction a very high standard, a credit a good standard, and a pass an acceptable standard.

Result name

Mark range

Description

High distinction

85 - 100

At HD level, a student demonstrates an aptitude for the subject and a well-developed understanding of the unit material. A ‘High Distinction’ reflects exceptional achievement and is awarded to students who demonstrate the ability to apply their subject knowledge and understanding to produce original solutions for novel or highly complex problems and/or comprehensive critical discussions of theoretical concepts.

Distinction

75 - 84

At DI level, a student demonstrates an aptitude for the subject and a well-developed understanding of the units material. A ‘Distinction’ reflects excellent achievement and is awarded to a student who demonstrates an ability to apply their subject knowledge and understanding of the subject to produce good solutions for challenging problems and/or a reasonably well-developed critical analysis of theoretical concepts.

Credit

65 - 74

At CR level, a student demonstrates a good command and knowledge of the unit material. A ‘Credit’ reflects solid achievement and is awarded to a student who has a broad general understanding of the units material and can solve routine problems and/ or identify and superficially discuss theoretical concepts.

Pass

50 - 64

At PS level, a student demonstrates proficiency in the material. A ‘Pass’ reflects satisfactory adequately referencing the original source of the work.

Fail

0 - 49

When you don’t meet the learning outcomes of the unit to a satisfactory standard.

For more information see guide to grades.

Use of generative artificial intelligence (AI)

You can use generative AI tools for open assessments. Restrictions on AI use apply to secure, supervised assessments used to confirm if students have met specific learning outcomes.

Refer to the assessment table above to see if AI is allowed, for assessments in this unit and check Canvas for full instructions on assessment tasks and AI use.

If you use AI, you must always acknowledge it. Misusing AI may lead to a breach of the Academic Integrity Policy.

Visit the Current Students website for more information on AI in assessments, including details on how to acknowledge its use.

Late submission

In accordance with University policy, these penalties apply when written work is submitted after 11:59pm on the due date:

  • Deduction of 5% of the maximum mark for each calendar day after the due date.
  • After ten calendar days late, a mark of zero will be awarded.

Academic integrity

The University expects students to act ethically and honestly and will treat all allegations of academic integrity breaches seriously.

Our website provides information on academic integrity and the resources available to all students. This includes advice on how to avoid common breaches of academic integrity. Ensure that you have completed the Academic Honesty Education Module (AHEM) which is mandatory for all commencing coursework students

Penalties for serious breaches can significantly impact your studies and your career after graduation. It is important that you speak with your unit coordinator if you need help with completing assessments.

Visit the Current Students website for more information on AI in assessments, including details on how to acknowledge its use.

Simple extensions

If you encounter a problem submitting your work on time, you may be able to apply for an extension of five calendar days through a simple extension.  The application process will be different depending on the type of assessment and extensions cannot be granted for some assessment types like exams.

Special consideration

If exceptional circumstances mean you can’t complete an assessment, you need consideration for a longer period of time, or if you have essential commitments which impact your performance in an assessment, you may be eligible for special consideration or special arrangements.

Special consideration applications will not be affected by a simple extension application.

Using AI responsibly

Co-created with students, AI in Education includes lots of helpful examples of how students use generative AI tools to support their learning. It explains how generative AI works, the different tools available and how to use them responsibly and productively.

Support for students

The Support for Students Policy reflects the University’s commitment to supporting students in their academic journey and making the University safe for students. It is important that you read and understand this policy so that you are familiar with the range of support services available to you and understand how to engage with them.

The University uses email as its primary source of communication with students who need support under the Support for Students Policy. Make sure you check your University email regularly and respond to any communications received from the University.

Learning resources and detailed information about weekly assessment and learning activities can be accessed via Canvas. It is essential that you visit your unit of study Canvas site to ensure you are up to date with all of your tasks.

If you are having difficulties completing your studies, or are feeling unsure about your progress, we are here to help. You can access the support services offered by the University at any time:

Support and Services (including health and wellbeing services, financial support and learning support)
Course planning and administration
Meet with an Academic Adviser

WK Topic Learning activity Learning outcomes
Week 01 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (4 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 02 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 03 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 04 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 05 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 06 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 07 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 08 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 09 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 10 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 11 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 12 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Interactive small group case-based learning emphasising the application of 'processes' in practising as a pharmacist in cancer and immunology disorders cases, especially communication processes incorporating information gathering, information processing and information delivery. Workshop (3 hr) LO1 LO3 LO2 LO4 LO5 LO6 LO7 LO8
Week 13 Lectures and Q+A discussion covering cancer and immunological disorders topics and vaccination pre-recording lectures Lecture (3 hr) LO1 LO3 LO2 LO4 LO6 LO7
Weekly Learn independently, including completing prework and postwork and vaccination online modules Self-directed learning (65 hr) LO1 LO3 LO2 LO4 LO6 LO7

Attendance and class requirements

Attendance: In accordance with the Master of Pharmacy Course resolutions on Attendance Requirements, students must attend a minimum of 85% case tutorials to satisfy attendance requirements for this unit of study.  

If a tutorial is missed due to illness or misadventure, students are to submit a special consideration application along with supporting documentation. For approved special consideration, the coordinator will provide an alternative assessment for the student to complete before the next case.

Students arriving more than 10 minutes after the commencement of the tutorials will be considered absent.

Study commitment

Typically, there is a minimum expectation of 1.5-2 hours of student effort per week per credit point for units of study offered over a full semester. For a 6 credit point unit, this equates to roughly 120-150 hours of student effort in total.

Required readings

All readings for this unit can be accessed through the Library’s reading list system Leganto, available on Canvas

Australian Medicines Handbook, current edition

eTG complete, current edition

Learning outcomes are what students know, understand and are able to do on completion of a unit of study. They are aligned with the University's graduate qualities and are assessed as part of the curriculum.

At the completion of this unit, you should be able to:

  • LO1. Demonstrate an understanding of the epidemiology and pathophysiology associated with immunological disorders and cancer
  • LO2. Identify the most appropriate evidence-based treatments and the appropriate advice and counselling to patients with immunological disorders and cancer
  • LO3. Demonstrate an understanding of the chemistry and pharmacology that forms the basis of structure-activity relationships, drug-drug interactions, and drug design of medicines used for immunological disorders and cancer
  • LO4. Identify and manage medication-related adverse events and provide appropriate advice/counselling to patients with immunological disorders and cancer or other health care professionals
  • LO5. Communicate effectively and ethically with patients, their families, and other health care professionals about the optimal management of immunological disorders and cancer
  • LO6. Identify and utilise appropriate resources that are used to form the basis of decisions on which medicines and services are recommended to patients with immunological disorders and cancer and other health care professionals
  • LO7. Critically examine scientific evidence, both quantitative and qualitative, in order to arrive at evidence-based conclusions
  • LO8. Work effectively and cooperatively as a member of a learning team

Graduate qualities

The graduate qualities are the qualities and skills that all University of Sydney graduates must demonstrate on successful completion of an award course. As a future Sydney graduate, the set of qualities have been designed to equip you for the contemporary world.

GQ1 Depth of disciplinary expertise

Deep disciplinary expertise is the ability to integrate and rigorously apply knowledge, understanding and skills of a recognised discipline defined by scholarly activity, as well as familiarity with evolving practice of the discipline.

GQ2 Critical thinking and problem solving

Critical thinking and problem solving are the questioning of ideas, evidence and assumptions in order to propose and evaluate hypotheses or alternative arguments before formulating a conclusion or a solution to an identified problem.

GQ3 Oral and written communication

Effective communication, in both oral and written form, is the clear exchange of meaning in a manner that is appropriate to audience and context.

GQ4 Information and digital literacy

Information and digital literacy is the ability to locate, interpret, evaluate, manage, adapt, integrate, create and convey information using appropriate resources, tools and strategies.

GQ5 Inventiveness

Generating novel ideas and solutions.

GQ6 Cultural competence

Cultural Competence is the ability to actively, ethically, respectfully, and successfully engage across and between cultures. In the Australian context, this includes and celebrates Aboriginal and Torres Strait Islander cultures, knowledge systems, and a mature understanding of contemporary issues.

GQ7 Interdisciplinary effectiveness

Interdisciplinary effectiveness is the integration and synthesis of multiple viewpoints and practices, working effectively across disciplinary boundaries.

GQ8 Integrated professional, ethical, and personal identity

An integrated professional, ethical and personal identity is understanding the interaction between one’s personal and professional selves in an ethical context.

GQ9 Influence

Engaging others in a process, idea or vision.

Outcome map

Learning outcomes Graduate qualities
GQ1 GQ2 GQ3 GQ4 GQ5 GQ6 GQ7 GQ8 GQ9

Alignment with Competency standards

Outcomes Competency standards
LO1
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
3. Domain 3 Professional expertise
3.0. D3 Professional expertise
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10. facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.17. providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.18. assessing ambulatory conditions and recommending appropriate management approaches, including pharmacological, non-pharmacological and referral options where appropriate
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.20. providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.22. endorsing and participating in health promotion activities, health services and public health initiatives intended to maintain and improve health
3.5. demonstrating the delivery of person-centred care including
3.5.e. ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.6. obtaining relevant health, medical and medication information from patients, carers and other clients
3.7. assessing current health, medical and medication histories and profiles of patients
3.9. recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
LO2
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
1.0. D1 Professionalism in practice
1.1. promoting both the best interests and safety of patients and the public
1.2. promoting and advocating for cultural safety, respect and responsiveness, particularly in relation to Aboriginal and Torres Strait Islander and/or Māori peoples
1.3. recognising the presence and causes of health inequities and disparities, including the impact of social determinants of health
1.5. practising ethically and with integrity by
1.5.a. identifying potential ethical issues and dilemmas, including conflicts of interest, relating to practice
1.5.b. considering alternative strategies and choosing an appropriate course of action in response to ethical issues and dilemmas
1.5.c. demonstrating awareness of relevant professional codes, guidelines and standards and their content
1.5.d. recognising and formulating strategies to respond appropriately to situations which fall outside their expected scope of practice or competence
2. Domain 2 Communication and collaboration
2.0. D2 Communication and collaboration
2.1. communicating appropriately and effectively with a socially and culturally diverse range of people in a manner which inspires confidence and trust by
2.1.a. demonstrating appropriately tailored verbal, written and non-verbal communication
2.1.b. engaging with all persons in a respectful, culturally appropriate, compassionate, responsive and empathetic manner
2.1.d. demonstrating appropriate communication and interpersonal behaviours
2.2. documenting, communicating and recording relevant information, findings, decisions, recommendations and other information accurately and concisely, taking due account of privacy and confidentiality
2.3. contributing to the interprofessional collaborative health care team in order to optimise patient outcomes by
2.3.a. demonstrating an understanding and appreciation of the roles of pharmacists and other members of the interprofessional collaborative care team
2.3.d. demonstrating appropriate communication at transition points in patient care to reduce risks to patients and ensure safe and effective continuity of patient care
2.4. collaborating with patients, carers and other clients in shared decision-making by
2.4.a. supporting the rights of patients, carers and other clients to access relevant information and participate in decisions relating to their care
2.4.b. respecting their choices
3. Domain 3 Professional expertise
3.0. D3 Professional expertise
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10. facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.12. consistently making accurate arithmetic calculations relating to health care
3.16. demonstrating awareness of the appropriate conditions for secure and safe storage and distribution of medications to ensure stability and efficacy
3.17. providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.18. assessing ambulatory conditions and recommending appropriate management approaches, including pharmacological, non-pharmacological and referral options where appropriate
3.19. demonstrating the delivery of measures designed to enhance adherence with dosage regimens and support safe and effective administration of medications
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.20. providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.21. demonstrating the delivery of harm minimisation approaches and strategies to reduce harm to patients and the community from misuse of legal and illegal drugs
3.22. endorsing and participating in health promotion activities, health services and public health initiatives intended to maintain and improve health
3.3. prescribing medications in accordance with current jurisdiction-specific legislation, scope of practice and PharmBA Guidelines
3.4. carrying out systematic medication reviews, informed by the Quality Use of Medicines Framework, in order to identify and resolve potential medication-related issues and optimise the impact of medications on health outcomes in collaboration with patients, carers and other members of the health care team
3.5. demonstrating the delivery of person-centred care including
3.5.a. respecting the personal characteristics, rights, preferences, values, beliefs, needs and diversity of patients, carers and other persons
3.5.b. maintaining privacy and confidentiality in interactions with patients, carers and other persons
3.5.c. optimising as far as is practicable the physical environment in which care takes place
3.5.d. ensuring that the best interests of patients, carers and other persons are foremost in the provision of care
3.5.e. ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.5.f. ensuring that informed consent is obtained, respected and appropriately recorded when appropriate
3.6. obtaining relevant health, medical and medication information from patients, carers and other clients
3.7. assessing current health, medical and medication histories and profiles of patients
3.8. formulating health, medical and medication management plans in collaboration with patients, carers and other health team members
3.9. recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
4. Domain 4 Leadership and management
4.0. D4 Leadership and management
4.10. demonstrating awareness of, and complying with appropriate policies, processes and protocols
4.11. demonstrating skills in the identification, assessment, monitoring, mitigation and management of risk
4.2. demonstrating awareness of professional limitations and adopting appropriate strategies where necessary, including additional professional education and/or referral of patients to other health care professionals
4.7. demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
5. Domain 5 Research, inquiry and education
5.0. D5 Research, inquiry and education
5.3. demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
LO3
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
2. Domain 2 Communication and collaboration
2.0. D2 Communication and collaboration
2.1. communicating appropriately and effectively with a socially and culturally diverse range of people in a manner which inspires confidence and trust by
2.1.a. demonstrating appropriately tailored verbal, written and non-verbal communication
2.2. documenting, communicating and recording relevant information, findings, decisions, recommendations and other information accurately and concisely, taking due account of privacy and confidentiality
2.3. contributing to the interprofessional collaborative health care team in order to optimise patient outcomes by
2.3.d. demonstrating appropriate communication at transition points in patient care to reduce risks to patients and ensure safe and effective continuity of patient care
2.4. collaborating with patients, carers and other clients in shared decision-making by
2.4.a. supporting the rights of patients, carers and other clients to access relevant information and participate in decisions relating to their care
3. Domain 3 Professional expertise
3.0. D3 Professional expertise
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.12. consistently making accurate arithmetic calculations relating to health care
3.16. demonstrating awareness of the appropriate conditions for secure and safe storage and distribution of medications to ensure stability and efficacy
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.21. demonstrating the delivery of harm minimisation approaches and strategies to reduce harm to patients and the community from misuse of legal and illegal drugs
3.4. carrying out systematic medication reviews, informed by the Quality Use of Medicines Framework, in order to identify and resolve potential medication-related issues and optimise the impact of medications on health outcomes in collaboration with patients, carers and other members of the health care team
5. Domain 5 Research, inquiry and education
5.0. D5 Research, inquiry and education
5.1. demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.2. demonstrating awareness of effective processes for facilitating learning, including aims, learning outcomes, learning activities, assessment and feedback
5.3. demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO4
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
1. Domain 1 Professionalism in practice
1.0. D1 Professionalism in practice
1.1. promoting both the best interests and safety of patients and the public
1.2. promoting and advocating for cultural safety, respect and responsiveness, particularly in relation to Aboriginal and Torres Strait Islander and/or Māori peoples
1.3. recognising the presence and causes of health inequities and disparities, including the impact of social determinants of health
2. Domain 2 Communication and collaboration
2.0. D2 Communication and collaboration
2.1. communicating appropriately and effectively with a socially and culturally diverse range of people in a manner which inspires confidence and trust by
2.1.a. demonstrating appropriately tailored verbal, written and non-verbal communication
2.1.b. engaging with all persons in a respectful, culturally appropriate, compassionate, responsive and empathetic manner
2.1.d. demonstrating appropriate communication and interpersonal behaviours
2.2. documenting, communicating and recording relevant information, findings, decisions, recommendations and other information accurately and concisely, taking due account of privacy and confidentiality
2.3. contributing to the interprofessional collaborative health care team in order to optimise patient outcomes by
2.3.a. demonstrating an understanding and appreciation of the roles of pharmacists and other members of the interprofessional collaborative care team
2.3.b. creating and maintaining effective intra- and interprofessional relationships, and working in partnership to achieve negotiated, agreed-upon objectives
2.3.c. demonstrating appropriate teamwork behaviours
2.3.d. demonstrating appropriate communication at transition points in patient care to reduce risks to patients and ensure safe and effective continuity of patient care
2.4. collaborating with patients, carers and other clients in shared decision-making by
2.4.a. supporting the rights of patients, carers and other clients to access relevant information and participate in decisions relating to their care
2.4.b. respecting their choices
3. Domain 3 Professional expertise
3.0. D3 Professional expertise
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10. facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.11. responding to the needs of individuals and communities by advocating with and for them to optimise health and societal outcomes
3.12. consistently making accurate arithmetic calculations relating to health care
3.16. demonstrating awareness of the appropriate conditions for secure and safe storage and distribution of medications to ensure stability and efficacy
3.17. providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.18. assessing ambulatory conditions and recommending appropriate management approaches, including pharmacological, non-pharmacological and referral options where appropriate
3.19. demonstrating the delivery of measures designed to enhance adherence with dosage regimens and support safe and effective administration of medications
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.20. providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.21. demonstrating the delivery of harm minimisation approaches and strategies to reduce harm to patients and the community from misuse of legal and illegal drugs
3.22. endorsing and participating in health promotion activities, health services and public health initiatives intended to maintain and improve health
3.3. prescribing medications in accordance with current jurisdiction-specific legislation, scope of practice and PharmBA Guidelines
3.4. carrying out systematic medication reviews, informed by the Quality Use of Medicines Framework, in order to identify and resolve potential medication-related issues and optimise the impact of medications on health outcomes in collaboration with patients, carers and other members of the health care team
3.5. demonstrating the delivery of person-centred care including
3.5.a. respecting the personal characteristics, rights, preferences, values, beliefs, needs and diversity of patients, carers and other persons
3.5.b. maintaining privacy and confidentiality in interactions with patients, carers and other persons
3.5.c. optimising as far as is practicable the physical environment in which care takes place
3.5.d. ensuring that the best interests of patients, carers and other persons are foremost in the provision of care
3.5.e. ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.5.f. ensuring that informed consent is obtained, respected and appropriately recorded when appropriate
3.6. obtaining relevant health, medical and medication information from patients, carers and other clients
3.7. assessing current health, medical and medication histories and profiles of patients
3.8. formulating health, medical and medication management plans in collaboration with patients, carers and other health team members
3.9. recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
4. Domain 4 Leadership and management
4.0. D4 Leadership and management
4.2. demonstrating awareness of professional limitations and adopting appropriate strategies where necessary, including additional professional education and/or referral of patients to other health care professionals
4.7. demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
5. Domain 5 Research, inquiry and education
5.0. D5 Research, inquiry and education
5.1. demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.3. demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO5
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
1. Domain 1 Professionalism in practice
1.0. D1 Professionalism in practice
1.1. promoting both the best interests and safety of patients and the public
1.2. promoting and advocating for cultural safety, respect and responsiveness, particularly in relation to Aboriginal and Torres Strait Islander and/or Māori peoples
1.3. recognising the presence and causes of health inequities and disparities, including the impact of social determinants of health
1.5. practising ethically and with integrity by
1.5.a. identifying potential ethical issues and dilemmas, including conflicts of interest, relating to practice
1.5.b. considering alternative strategies and choosing an appropriate course of action in response to ethical issues and dilemmas
1.5.c. demonstrating awareness of relevant professional codes, guidelines and standards and their content
1.5.d. recognising and formulating strategies to respond appropriately to situations which fall outside their expected scope of practice or competence
2. Domain 2 Communication and collaboration
2.0. D2 Communication and collaboration
2.1. communicating appropriately and effectively with a socially and culturally diverse range of people in a manner which inspires confidence and trust by
2.1.a. demonstrating appropriately tailored verbal, written and non-verbal communication
2.1.b. engaging with all persons in a respectful, culturally appropriate, compassionate, responsive and empathetic manner
2.1.d. demonstrating appropriate communication and interpersonal behaviours
2.2. documenting, communicating and recording relevant information, findings, decisions, recommendations and other information accurately and concisely, taking due account of privacy and confidentiality
2.3. contributing to the interprofessional collaborative health care team in order to optimise patient outcomes by
2.3.a. demonstrating an understanding and appreciation of the roles of pharmacists and other members of the interprofessional collaborative care team
2.3.b. creating and maintaining effective intra- and interprofessional relationships, and working in partnership to achieve negotiated, agreed-upon objectives
2.3.c. demonstrating appropriate teamwork behaviours
2.3.d. demonstrating appropriate communication at transition points in patient care to reduce risks to patients and ensure safe and effective continuity of patient care
2.4. collaborating with patients, carers and other clients in shared decision-making by
2.4.a. supporting the rights of patients, carers and other clients to access relevant information and participate in decisions relating to their care
2.4.b. respecting their choices
3. Domain 3 Professional expertise
3.0. D3 Professional expertise
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10. facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.11. responding to the needs of individuals and communities by advocating with and for them to optimise health and societal outcomes
3.16. demonstrating awareness of the appropriate conditions for secure and safe storage and distribution of medications to ensure stability and efficacy
3.17. providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.18. assessing ambulatory conditions and recommending appropriate management approaches, including pharmacological, non-pharmacological and referral options where appropriate
3.19. demonstrating the delivery of measures designed to enhance adherence with dosage regimens and support safe and effective administration of medications
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.20. providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.21. demonstrating the delivery of harm minimisation approaches and strategies to reduce harm to patients and the community from misuse of legal and illegal drugs
3.22. endorsing and participating in health promotion activities, health services and public health initiatives intended to maintain and improve health
3.4. carrying out systematic medication reviews, informed by the Quality Use of Medicines Framework, in order to identify and resolve potential medication-related issues and optimise the impact of medications on health outcomes in collaboration with patients, carers and other members of the health care team
3.5. demonstrating the delivery of person-centred care including
3.5.a. respecting the personal characteristics, rights, preferences, values, beliefs, needs and diversity of patients, carers and other persons
3.5.b. maintaining privacy and confidentiality in interactions with patients, carers and other persons
3.5.c. optimising as far as is practicable the physical environment in which care takes place
3.5.d. ensuring that the best interests of patients, carers and other persons are foremost in the provision of care
3.5.e. ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.5.f. ensuring that informed consent is obtained, respected and appropriately recorded when appropriate
3.6. obtaining relevant health, medical and medication information from patients, carers and other clients
3.7. assessing current health, medical and medication histories and profiles of patients
3.8. formulating health, medical and medication management plans in collaboration with patients, carers and other health team members
3.9. recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
4. Domain 4 Leadership and management
4.0. D4 Leadership and management
4.11. demonstrating skills in the identification, assessment, monitoring, mitigation and management of risk
4.2. demonstrating awareness of professional limitations and adopting appropriate strategies where necessary, including additional professional education and/or referral of patients to other health care professionals
4.7. demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
4.8. demonstrating awareness of the importance of, and strategies for, promoting responsible and socially accountable stewardship of health care resources
4.9. promoting quality assurance and continuous quality improvement strategies through utilising skills in collaboration, critical thinking, curiosity and creativity
5. Domain 5 Research, inquiry and education
5.0. D5 Research, inquiry and education
5.1. demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.2. demonstrating awareness of effective processes for facilitating learning, including aims, learning outcomes, learning activities, assessment and feedback
5.3. demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4. demonstrating skills in research and inquiry, including
5.4.b. identifying and critically appraising relevant source materials
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO6
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
3. Domain 3 Professional expertise
3.0. D3 Professional expertise
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10. facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.17. providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.18. assessing ambulatory conditions and recommending appropriate management approaches, including pharmacological, non-pharmacological and referral options where appropriate
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.20. providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.22. endorsing and participating in health promotion activities, health services and public health initiatives intended to maintain and improve health
3.4. carrying out systematic medication reviews, informed by the Quality Use of Medicines Framework, in order to identify and resolve potential medication-related issues and optimise the impact of medications on health outcomes in collaboration with patients, carers and other members of the health care team
3.8. formulating health, medical and medication management plans in collaboration with patients, carers and other health team members
3.9. recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
5. Domain 5 Research, inquiry and education
5.0. D5 Research, inquiry and education
5.1. demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.3. demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.f. identifying ways in which the outcomes can be applied to practice
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO7
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
3. Domain 3 Professional expertise
3.0. D3 Professional expertise
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
5. Domain 5 Research, inquiry and education
5.0. D5 Research, inquiry and education
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO8
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
2.0. D2 Communication and collaboration
2.1. communicating appropriately and effectively with a socially and culturally diverse range of people in a manner which inspires confidence and trust by
2.1.a. demonstrating appropriately tailored verbal, written and non-verbal communication
2.1.b. engaging with all persons in a respectful, culturally appropriate, compassionate, responsive and empathetic manner
2.1.d. demonstrating appropriate communication and interpersonal behaviours
2.3.b. creating and maintaining effective intra- and interprofessional relationships, and working in partnership to achieve negotiated, agreed-upon objectives
2.3.c. demonstrating appropriate teamwork behaviours
4. Domain 4 Leadership and management
4.0. D4 Leadership and management
4.1. undertaking regular reflection as a means of enhancing learning and practice
4.3. demonstrating self-awareness and self-regulation of personal attributes, strengths and weaknesses which may affect professional performance and/or personal development
4.5. recognising situations likely to compromise performance and developing effective strategies to minimise their impact
4.6. evaluating personal health and wellbeing status, identifying situations where health or wellbeing may be challenged, and developing appropriate strategies and mechanisms to minimise their impact on personal and professional life
4.7. demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
5. Domain 5 Research, inquiry and education
5.0. D5 Research, inquiry and education
5.1. demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.2. demonstrating awareness of effective processes for facilitating learning, including aims, learning outcomes, learning activities, assessment and feedback
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program -
Competency code Taught, Practiced or Assessed Competency standard
1.0 A D1 Professionalism in practice
1.1 A promoting both the best interests and safety of patients and the public
1.2 T A promoting and advocating for cultural safety, respect and responsiveness, particularly in relation to Aboriginal and Torres Strait Islander and/or Māori peoples
1.3 P A recognising the presence and causes of health inequities and disparities, including the impact of social determinants of health
1.4.a A demonstrating contemporary knowledge and application of legal requirements relating to community and hospital pharmacy practice within their jurisdiction
1.4.b A demonstrating awareness of the processes for maintaining contemporary familiarity with key legislative instruments
1.5.a A identifying potential ethical issues and dilemmas, including conflicts of interest, relating to practice
1.5.b A considering alternative strategies and choosing an appropriate course of action in response to ethical issues and dilemmas
1.5.c A demonstrating awareness of relevant professional codes, guidelines and standards and their content
1.5.d A recognising and formulating strategies to respond appropriately to situations which fall outside their expected scope of practice or competence
1.6 A demonstrating a proactive and reflective approach to developing their own professional competence and expertise
1.8 A accepting personal responsibility and accountability for decisions and actions in simulated and/or work-integrated learning environments
1.9 A upholding and maintaining the reputation and value of the profession
2.0 A D2 Communication and collaboration
2.1.a A demonstrating appropriately tailored verbal, written and non-verbal communication
2.1.b A engaging with all persons in a respectful, culturally appropriate, compassionate, responsive and empathetic manner
2.1.d A demonstrating appropriate communication and interpersonal behaviours
2.2 A documenting, communicating and recording relevant information, findings, decisions, recommendations and other information accurately and concisely, taking due account of privacy and confidentiality
2.3.a A demonstrating an understanding and appreciation of the roles of pharmacists and other members of the interprofessional collaborative care team
2.3.b A creating and maintaining effective intra- and interprofessional relationships, and working in partnership to achieve negotiated, agreed-upon objectives
2.3.c A demonstrating appropriate teamwork behaviours
2.3.d A demonstrating appropriate communication at transition points in patient care to reduce risks to patients and ensure safe and effective continuity of patient care
2.4.a A supporting the rights of patients, carers and other clients to access relevant information and participate in decisions relating to their care
2.4.b A respecting their choices
3.0 A D3 Professional expertise
3.1.a A applying relevant underpinning knowledge
3.1.b A using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c A applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d A making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10 A facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.11 A responding to the needs of individuals and communities by advocating with and for them to optimise health and societal outcomes
3.12 A consistently making accurate arithmetic calculations relating to health care
3.16 A demonstrating awareness of the appropriate conditions for secure and safe storage and distribution of medications to ensure stability and efficacy
3.17 A providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.18 A assessing ambulatory conditions and recommending appropriate management approaches, including pharmacological, non-pharmacological and referral options where appropriate
3.19 A demonstrating the delivery of measures designed to enhance adherence with dosage regimens and support safe and effective administration of medications
3.2 A making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.20 A providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.21 A demonstrating the delivery of harm minimisation approaches and strategies to reduce harm to patients and the community from misuse of legal and illegal drugs
3.22 A endorsing and participating in health promotion activities, health services and public health initiatives intended to maintain and improve health
3.5.a A respecting the personal characteristics, rights, preferences, values, beliefs, needs and diversity of patients, carers and other persons
3.5.b A maintaining privacy and confidentiality in interactions with patients, carers and other persons
3.5.c A optimising as far as is practicable the physical environment in which care takes place
3.5.d A ensuring that the best interests of patients, carers and other persons are foremost in the provision of care
3.5.e A ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.5.f A ensuring that informed consent is obtained, respected and appropriately recorded when appropriate
3.6 A obtaining relevant health, medical and medication information from patients, carers and other clients
3.7 A assessing current health, medical and medication histories and profiles of patients
3.8 A formulating health, medical and medication management plans in collaboration with patients, carers and other health team members
3.9 A recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
4.0 A D4 Leadership and management
4.10 A demonstrating awareness of, and complying with appropriate policies, processes and protocols
4.11 A demonstrating skills in the identification, assessment, monitoring, mitigation and management of risk
4.2 A demonstrating awareness of professional limitations and adopting appropriate strategies where necessary, including additional professional education and/or referral of patients to other health care professionals
4.3 A demonstrating self-awareness and self-regulation of personal attributes, strengths and weaknesses which may affect professional performance and/or personal development
4.4 A demonstrating awareness of the signs which indicate that a potential risk to public safety may exist if observed in another practitioner, and formulating appropriate responses including support, advice, assistance, referral or reporting where necessary
4.5 A recognising situations likely to compromise performance and developing effective strategies to minimise their impact
4.6 A evaluating personal health and wellbeing status, identifying situations where health or wellbeing may be challenged, and developing appropriate strategies and mechanisms to minimise their impact on personal and professional life
4.7 A demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
4.8 A demonstrating awareness of the importance of, and strategies for, promoting responsible and socially accountable stewardship of health care resources
4.9 A promoting quality assurance and continuous quality improvement strategies through utilising skills in collaboration, critical thinking, curiosity and creativity
5.0 A D5 Research, inquiry and education
5.1 A demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.2 A demonstrating awareness of effective processes for facilitating learning, including aims, learning outcomes, learning activities, assessment and feedback
5.3 A demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4.a A formulating questions
5.4.b A identifying and critically appraising relevant source materials
5.4.c A undertaking relevant investigations, where appropriate
5.4.d A drawing conclusions by synthesising the results of research and inquiry activities
5.4.e A reporting and disseminating the outcomes appropriately
5.4.f A identifying ways in which the outcomes can be applied to practice
5.5 A accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice

This section outlines changes made to this unit following staff and student reviews.

We have adopted students' feedback on several levels: the unit of study now has fewer assessment tasks, is better aligned with other unit of studies in terms of timing of assessments, and is richer in lectures on the practicality of oncology and immunology.

Disclaimer

Important: the University of Sydney regularly reviews units of study and reserves the right to change the units of study available annually. To stay up to date on available study options, including unit of study details and availability, refer to the relevant handbook.

To help you understand common terms that we use at the University, we offer an online glossary.